Investigation of Lipedema, Lymphedema and Vascular Malformations by Multispectral Optoacoustic Tomography (MSOT)

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions
LipedemaLymphedemaVascular Malformations
Interventions
DIAGNOSTIC_TEST

MSOT

The MSOT system used consists of a laser in the visible near-infrared and far-infrared wavelength range (660nm-1300nm) and an ultrasonic sensor connected to a computer. Using optical components, the area to be measured is illuminated with ultra-short light pulses of selectable wavelength. The light is absorbed to varying degrees inside the object - depending on the properties of the tissue. The absorption of light leads to local microscopic volume fluctuations and thereby emits pressure waves in the ultrasonic range (photoacoustic effect). MSOT enables non-invasive, non-ionizing 2D imaging with high spatial resolution (80 μm), which enables specific visualization of endogenous tissue pigments such as collagen fibers, fat, melanin, oxyhemoglobin and deoxyhemoglobin.

Trial Locations (1)

37075

Universitätsmedizin Göttingen, Göttingen

All Listed Sponsors
lead

University Hospital Goettingen

OTHER